CDDO-dhTFEA [1191265-33-4]

TargetMol Chemicals

CDDO-dhTFEA [1191265-33-4]

4

1191265-33-4

Chemical

Research Use Only

CDDO-dhTFEA

98.88%

C33H45F3N2O3

574.72

CDDO-dhTFEA, a synthetic oleanane triterpenoid, effectively activates Nrf2 while inhibiting the NF-kappaB pro-inflammatory transcription factor. It restores mean arterial pressure (MAP), elevates Nrf2 levels and the expression of related genes, attenuates NF-kappaB and transforming growth factor-beta pathway activation, and mitigates glomerulosclerosis, interstitial fibrosis, and inflammation in rats with chronic kidney disease (CKD).

3 years

[H][C@@]12CC(C)(C)CC[C@@]1(CC[C@]1(C)[C@]2([H])C(=O)C[C@@]2([H])[C@@]1(C)CC[C@@]1([H])C(C)(C)C(=O)C(=C[C@]21C)C#N)C(=O)NCC(F)(F)F

-20°C

12352200